Information and control
This article was originally published in Scrip
The European Commission has put out its proposals for a regulation on public information on prescription drugs. Essentially designed to stop direct to consumer advertising, the regulation creates an editorial office at the European Medicines Agency at a cost of some €3 million a year that will examine written or electronic materials that companies want to put out on their drugs. There will be additional costs at the national regulators, too. All costs, of course, will be covered by companies but ultimately passed on to healthcare payers.